This study investigated the role of CREB-binding protein (CBP)–β-catenin signalling on both the expression of the stem cell antigen CD133 and the PP2A–PTEN pathway in tumour-initiating cells (TICs) in liver cancer. The gene discussed is CREBBP; the disease is liver cancer.